The company will share clinical data on the effectiveness of its AI-powered embryo quality assessment assistant
By Nicola Finn, associate director at OggaDoon
The Isareli firm uses intrauterine drug-delivery technology to improve women’s health
With over 48 million couples experiencing infertility globally, nutrition has come under the spotlight
The diagnostic tool is able to identify cell changes that cannot always be seen with standard colposcopy
With serious impacts on women's mental health, perimenopause and menopause is costing UK economy 14 million working days per year
The fund seeks to make investment landscape more equitable and address inequities in healthcare
How the one-size-fits-all approach fails women and why it has to change
Intrauterine drug-delivery technology aims to improve women’s health and quality of life with ball-shaped device
The Israeli Women’s Health Innovation Centre aims to make top OB/GYN care available to everyone
